Home
|
Help
|
Contact
Sign in
WPRIM Management System>
DCMS
>
Journal of Lung Cancer
>
2003
>
2
>
1
Volume:
2
Issue:
1
1. Inhibiting NF-kappaB Activation by Triptolide Enhances TRAIL-induced Cell Death in Lung Cancer Cells.
Page:61—68
2. Relationship between Tumor Angiogenesis and Micrometastases in The Regional Lymph Nodes of Patient with Stage I Non-Small Cell Lung Cancer.
Page:54—60
3. Polymorphisms in ERCC1 and ERCC2/XPD and Survival in Non-Small-Cell Lung Cancer Patients Treated with Cisplatin Based Chemotherapy.
Page:44—53
4. Efficacy of Topotecan as a Second-Line Treatment of Small-Cell Lung Cancer in Patients with Refractory and Sensitive Disease: Retrospective Study.
Page:37—43
5. Lack of the Difference in Outcome between N2 and N3 Non-Small Cell Lung Cancer Patients Treated with Concurrent Chemoradiotherapy; A Retrospective Analysis of 186 Patients.
Page:31—36
6. Phase II Study of 3-D Conformal Radiotherapy and Concurrent MVP (Mitomycin-C+Vinblastine+Cisplatin) Chemotherapy for Unresectable Non-Small Cell Lung Cancer.
Page:23—30
7. Clinical Response of Docetaxel Plus Cisplatin and Paclitaxel Plus Carboplatin Chemotherpy in Non-Small Cell Lung Cancer.
Page:16—22
8. Molecular Aspects of Radiotherapy.
Page:10—15
9. Adjuvant Chemotherapy for Completely Resected Non-Small Cell Lung Cancer.
Page:6—9
10. Screening for Lung Cancer with Low-Dose Computed Tomography.
Page:1—5